Millions of people worldwide take GLP-1 medications. Michael Siluk/Universal Images Group via Getty Images GLP-1 drugs must now carry a warning label about a potential link to a rare eye condition that can result in vision loss, the U.S. Food and Drug Administration announced on Nov. 9. 2026. The eye condition is…
theconversation.com/us ↗